$IOR
INCOME OPPORTUNITY REALTY INVESTORS INC /TX/

2023 Q2 Form 10-Q Financial Statement

#000138713123006374 Filed on May 11, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $456.0K $537.0K $460.0K
YoY Change 33.72% 16.74% -12.21%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $456.0K $537.0K $460.0K
YoY Change 33.72% 16.74% -12.21%
Operating Profit -$456.0K -$537.0K -$460.0K
YoY Change 33.72% 16.74% -12.21%
Interest Expense $2.778M $1.866M $1.252M
YoY Change 93.86% 49.04% 2.79%
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00
YoY Change -100.0%
Pretax Income $2.322M $1.329M $792.0K
YoY Change 112.64% 67.8% -53.71%
Income Tax $488.0K $279.0K $166.0K
% Of Pretax Income 21.02% 20.99% 20.96%
Net Earnings $1.834M $1.050M $626.0K
YoY Change 116.27% 67.73% -53.7%
Net Earnings / Revenue
Basic Earnings Per Share $0.44 $0.25 $0.15
Diluted Earnings Per Share $0.44 $0.25 $150.2K
COMMON SHARES
Basic Shares Outstanding 4.168M shares 4.168M shares 4.168M shares
Diluted Shares Outstanding 4.168M shares 4.168M shares 4.168M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.000K $6.000K $5.000K
YoY Change 100.0% 20.0%
Cash & Equivalents $2.000K $6.000K $5.000K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $103.0M $101.6M $97.18M
Other Receivables $103.0M $101.6M $0.00
Total Short-Term Assets $103.7M $101.9M $97.18M
YoY Change 5.43% 4.85% 3.05%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $11.17M $11.17M $11.50M
YoY Change 0.0% -2.87% 0.0%
TOTAL ASSETS
Total Short-Term Assets $103.7M $101.9M $97.18M
Total Long-Term Assets $11.17M $11.17M $11.50M
Total Assets $114.9M $113.1M $108.7M
YoY Change 4.88% 4.03% 2.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.000K $35.00K $5.000K
YoY Change 0.0% 600.0% 150.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.000K $35.00K $5.000K
YoY Change 0.0% 600.0% 150.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.000K $35.00K $5.000K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.000K $35.00K $5.000K
YoY Change 0.0% 600.0% 150.0%
SHAREHOLDERS EQUITY
Retained Earnings $52.91M $51.08M
YoY Change 11.23%
Common Stock $62.00M $62.00M
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $39.00K $39.00K
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity $114.9M $113.0M $108.7M
YoY Change
Total Liabilities & Shareholders Equity $114.9M $113.1M $108.7M
YoY Change 4.88% 4.03% 2.72%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $1.834M $1.050M $626.0K
YoY Change 116.27% 67.73% -53.7%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$4.000K $3.000K
YoY Change 0.0% -100.1%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -4.000K 3.000K
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash -4.000K $0.00
YoY Change 0.0% -100.0%
FREE CASH FLOW
Cash From Operating Activities -$4.000K $3.000K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000949961
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4000 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
usd
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-14784
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
INCOME OPPORTUNITY REALTY INVESTORS, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
75-2615944
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1603 Lyndon B. Johnson Freeway
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 800
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Dallas
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75234
CY2023Q1 dei City Area Code
CityAreaCode
469
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
522-4200
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock
CY2023Q1 dei Trading Symbol
TradingSymbol
IOR
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4168414 shares
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6000 usd
CY2023Q1 us-gaap Interest Receivable
InterestReceivable
331000 usd
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
676000 usd
CY2023Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
101560000 usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
100134000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
101897000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
100816000 usd
CY2023Q1 us-gaap Notes Receivable Net
NotesReceivableNet
11173000 usd
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
11173000 usd
CY2023Q1 us-gaap Assets
Assets
113070000 usd
CY2022Q4 us-gaap Assets
Assets
111989000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
35000 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4173675 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1050000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
626000 usd
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4173675 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4168414 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4168414 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
42000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
42000 usd
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
5261 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
5261 shares
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
39000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
39000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
61955000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
61955000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
51077000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
50027000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
113035000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
111985000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
113070000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
111989000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
218000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
192000 usd
CY2023Q1 ior Advisory Fee To Related Party
AdvisoryFeeToRelatedParty
319000 usd
CY2022Q1 ior Advisory Fee To Related Party
AdvisoryFeeToRelatedParty
268000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
537000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
460000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-537000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-460000 usd
CY2023Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1866000 usd
CY2022Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1252000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
279000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
166000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1050000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
626000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.25
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4168414 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4168414 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4168414 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4168414 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
111985000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1050000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
113035000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
108054000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
626000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
108680000 usd
CY2023Q1 us-gaap Increase Decrease In Notes Receivable Related Parties
IncreaseDecreaseInNotesReceivableRelatedParties
-345000 usd
CY2022Q1 us-gaap Increase Decrease In Notes Receivable Related Parties
IncreaseDecreaseInNotesReceivableRelatedParties
-261000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
1426000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
877000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
31000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-7000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5000 usd
CY2023Q1 us-gaap Notes Receivable Net
NotesReceivableNet
11173000 usd
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
11173000 usd

Files In Submission

Name View Source Status
0001387131-23-006374-index-headers.html Edgar Link pending
0001387131-23-006374-index.html Edgar Link pending
0001387131-23-006374.txt Edgar Link pending
0001387131-23-006374-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ior-10q_033123.htm Edgar Link pending
ior-20230331.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ior-20230331_cal.xml Edgar Link unprocessable
ior-20230331_lab.xml Edgar Link unprocessable
ior-20230331_def.xml Edgar Link unprocessable
ior-20230331_pre.xml Edgar Link unprocessable
ior-10q_033123_htm.xml Edgar Link completed